The Oncology Impact Fund is a venture capital fund co-managed by MPM BioImpact and UBS Group, focusing on investing in private and public companies developing innovative treatments for cancer. Established in 2016, the fund aims to generate positive social impact alongside financial returns by supporting advancements in oncology.
Focus Areas
Notable Investments
